Determination of Dextromethorphan and Metabolites in Human Plasma and Urine by High-performance Liquid Chromatography with Fluorescence Detection
Overview
Affiliations
Sensitive methods were developed for the analysis of dextromethorphan (I) and two metabolites, (+)-17-methyl-morphinan-3-ol (II) and (+)-morphinan-3-ol (III), in plasma as well as dextromethorphan and three metabolites II, III and (+)-3-methoxymorphinan (IV) in urine using high-performance liquid chromatography followed by detection with a fluorometer. Dextromethorphan and its metabolites were extracted from plasma and urine and separated in the reversed-phase mode. The practical lower limits of determination for I, II, and III in plasma were 0.5, 5, and 5 ng/ml, respectively; for I, II, III, and IV in urine, the limits were 20 ng/ml, 0.6 microgram/ml, 0.5 microgram/ml, and 15 ng/ml, respectively. The linearity of the calibration graphs was excellent (r varied from 0.9994 to 0.9999) over concentration ranges of two orders of magnitude.
Funck-Brentano C, Boelle P, Verstuyft C, Bornert C, Becquemont L, Poirier J Eur J Clin Pharmacol. 2005; 61(11):821-9.
PMID: 16315033 DOI: 10.1007/s00228-005-0051-5.
Minor and clinically non-significant interaction between toloxatone and amitriptyline.
VANDEL S, Bertschy G, Perault M, SANDOZ M, Bouquet S, Chakroun R Eur J Clin Pharmacol. 1993; 44(1):97-9.
PMID: 8436164 DOI: 10.1007/BF00315289.
Mortimer O, Lindstrom B, Laurell H, Bergman U, Rane A Br J Clin Pharmacol. 1989; 27(2):223-7.
PMID: 2713216 PMC: 1379783. DOI: 10.1111/j.1365-2125.1989.tb05354.x.